GRITSTONE BIO INC (GRTS)

US39868T1051 - Common Stock

0.0322  -0.01 (-31.78%)

After market: 0.026 -0.01 (-19.25%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-6-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
14.62M16.34M19.95M48.21M4.04M
Operating Expenses
151.08M155.97M140.37M123.42M110.05M
Research and Development
119.55M127.18M111.40M97.49M88.64M
Selling, General, and Administrative Expenses
31.53M28.78M28.97M25.93M21.41M
Operating Income
-136.46M-139.62M-120.43M-75.21M-106.02M
Interest Income/Expense
-1.36M1.16M740.00K130.00K700.00K
Other Income/Expense
N/A-32.00KN/AN/AN/A
Income Before Taxes
-133.03M-138.49M-119.69M-75.08M-105.31M
Net Income
-133.03M-138.49M-119.69M-75.08M-105.31M
EBITDA
-129.23M-132.03M-113.87M-68.86M-99.38M
 
Per Share Data
EPS Diluted Total Ops
-1.34-1.52-1.32-0.95-2.79
Non GAAP EPS
-1.09-1.20-1.33-0.96-2.78
 
Statistics
Profit Margin
-910.16%-847.34%-599.95%-155.74%-2606.68%
Operating Profit Margin
-933.63%-854.26%-603.66%-156.00%-2624.26%

All data in USD

Charts